Stock Markets July 9, 2026 12:54 AM

Consortium Reaffirms A$7.7 Billion Bid for Steadfast, Wins Four-Week Extension on Exclusivity

Amwins and Dragoneer reconfirm intention to pursue A$6.00-per-share scheme; due diligence and exclusivity terms extended under process deed

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn

Steadfast Group said on Thursday that a consortium made up of U.S. insurance distributor Amwins Group and investment firm Dragoneer Investment Group has reconfirmed its intent to pursue a takeover proposal valuing the company at A$7.7 billion (US$5.34 billion). The reconfirmation extends an exclusivity period by four weeks under a process deed signed on June 10, 2026, while the consortium conducts due diligence on its non-binding proposal to acquire all outstanding shares via a scheme of arrangement. The proposed A$6.00-per-share offer is subject to reduction for any dividends or distributions declared or paid by Steadfast after June 5, 2026. The Steadfast board cautioned there is no assurance a binding agreement will be reached or that the proposal will result in a transaction.

Consortium Reaffirms A$7.7 Billion Bid for Steadfast, Wins Four-Week Extension on Exclusivity
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • A consortium of Amwins Group and Dragoneer Investment Group reconfirmed a non-binding takeover proposal valuing Steadfast at A$7.7 billion (US$5.34 billion).
  • Exclusivity under a process deed signed on June 10, 2026 was extended by four weeks while the consortium conducts due diligence on a proposed A$6.00-per-share scheme of arrangement.
  • The offer price will be reduced for any dividends or distributions declared or paid by Steadfast after June 5, 2026; sectors impacted include insurance, financial services, and equity markets.

Steadfast Group said on Thursday that a consortium composed of U.S. insurance distributor Amwins Group and investment firm Dragoneer Investment Group has reconfirmed its intention to move forward with a proposed takeover that values the company at A$7.7 billion, or about US$5.34 billion. The consortium's indicative price for the company is A$6.00 per share.

Under the terms of a process deed signed on June 10, 2026, the consortium has extended the exclusivity period by four weeks. During this extended window, the consortium will continue due diligence relating to its non-binding proposal, which contemplates acquiring all outstanding Steadfast shares through a scheme of arrangement.

The stated offer price of A$6.00 per share carries an explicit adjustment mechanism. It will be reduced to reflect any dividends or distributions that Steadfast declares or pays after June 5, 2026. That proviso remains part of the consortium's proposal and affects the final consideration shareholders might receive if a transaction proceeds.

The reconfirmation was required for the consortium to retain exclusive negotiating rights with Steadfast under the process deed. The company said the consortium needed to restate its intent to preserve those exclusive rights while due diligence is undertaken and negotiations continue.

The Steadfast board emphasized that the reconfirmation and extended exclusivity do not guarantee a deal. The board noted there is no assurance a binding agreement will be reached with the consortium and no certainty that the proposal will culminate in a transaction.

For now, the proposal remains non-binding and subject to the outcomes of due diligence, any necessary approvals, and the terms of a potential scheme of arrangement. The company's shareholders and market participants will be watching for further developments, including any formal agreement or changes to the offer conditions.


Context and next steps

The consortium's next actions will involve completing due diligence and deciding whether to proceed to a binding agreement. Should the parties reach a binding deal, the proposed acquisition would be executed through a scheme of arrangement, as outlined in the consortium's non-binding proposal.

The Steadfast board's public statement underlines the provisional nature of the current proposal and the conditional path that must be navigated before any transaction can be concluded.

Risks

  • There is no guarantee a binding agreement will be reached with the consortium, creating uncertainty for shareholders and market participants; this mainly affects equity markets and investor sentiment.
  • The A$6.00-per-share price is subject to reduction for any dividends or distributions declared or paid after June 5, 2026, which could lower expected proceeds for shareholders; this impacts shareholder returns and corporate finance planning.
  • The proposal remains non-binding and contingent on due diligence and subsequent approvals, leaving the outcome uncertain and potentially affecting the insurance and financial services sectors until clarity is achieved.

More from Stock Markets

Agrana posts 521% rise in Q1 operating profit as cost measures lift margins Jul 9, 2026 CICC Shares Spike After Robust H1 Profit Preview, Then Pare Gains as Sellers Emerge Jul 9, 2026 Barry Callebaut Posts First Quarterly Volume Gain in Over Two Years, But Full-Year Headwinds Persist Jul 9, 2026 Mitsubishi Materials Shares Plunge After ¥70 Billion Convertible Bond Plan Revealed Jul 9, 2026 Volkswagen stakeholders convene as sweeping restructuring plan faces union resistance Jul 9, 2026